Skip to main content

Soleus Capital Management, L.P.

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1802630 GREENWICH, CT

Position in XENE

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$16,979,800
+$14,513,360 QoQ
Shares Held
292,000
+270.6% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. XENE ranks #19 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,979,800 292,000
2025-06-30 $2,466,440 78,800
2023-12-31 $2,671,480 58,000
2023-09-30 $1,776,320 52,000
2023-06-30 $2,541,000 66,000
2022-12-31 $1,498,340 38,000
2022-09-30 $3,494,480 96,800
2022-06-30 $2,281,500 75,000
2022-03-31 $5,802,094 189,797
2021-12-31 $11,839,866 378,997
2021-09-30 $3,295,850 215,697
2021-06-30 $4,351,438 233,697
2021-03-31 $12,675,294 708,117
2020-12-31 $8,583,839 558,117
2020-09-30 $5,537,922 500,264
2020-06-30 $3,146,248 250,897
2020-03-31 $150,005 13,228